MD +.15 to 7.41, seems to be finding technical support in the low to mid $7's. I recently joined you with a small position. A year ago analyst EPS estimates for 2024 were $1.67 and they've dropped by 27% to $1.22, but the stock is down 47% since then and looks oversold despite diminished earnings expectations. Looks cheap with a forward PE of just 6, assuming they can hit the estimates.